| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.007 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |